Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA)-Reference-Cited by-同舟云学术

Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA)

Published:2012-04-06 Issue:1 Volume:16 Page:115-121
ISSN:1386-341X
Container-title:Pituitary
language:en
Short-container-title:Pituitary

Author:

Sesmilo Gemma, ,Gaztambide Sonia,Venegas Eva,Picó Antonio,Del Pozo Carlos,Blanco Concepción,Torres Elena,Álvarez-Escolà Cristina,Fajardo Carmen,García Rogelio,Cámara Rosa,Bernabeu Ignacio,Soto Alfonso,Villabona Carles,Serraclara Alicia,Halperin Irene,Alcázar Victoria,Palomera Elisabet,Webb Susan M.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11102-012-0384-x.pdf

Reference23 articles.

1. Etxabe J, Gaztambide S, Latorre P, Vazquez JA (1993) Acromegaly: an epidemiological study. J Endocrinol Invest 16:181–187

2. Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M, Gilabert M (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151:439–446

3. Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance ML, Ho K, Giustina A (2009) Guidelines for acromegaly management: an Update. J Clin Endocrinol Metab 94:1509–1517

4. Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF (2000) Davis RJ.T reatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342:1171–1177

5. Johnson MR, Chowdrey HS, Thomas F, Grint C, Lightman SL (1994) Pharmacokinetics and efficacy of the long-acting somatostatin analogue somatuline in acromegaly. Eur J Endocrinol 130:229–234

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades;Pituitary;2024-03-23

2. Long-term control of acromegaly after pituitary surgery in South-Eastern Norway;Acta Neurochirurgica;2023-09-04

3. Real World Data on the Epidemiology, Diagnosis, and Treatment of Acromegaly: A Registries-based Approach;Archives of Medical Research;2023-09

4. Caloric restriction as a possible pitfall for persistent acromegaly follow-up – case report;BMC Endocrine Disorders;2023-03-27

5. Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain;Frontiers in Endocrinology;2022-09-16